Effects from diet-induced gut microbiota dysbiosis and obesity can be ameliorated by fecal microbiota transplantation: A multiomics approach

• Published in: PloS one Vol. 14; no. 9; p. e0218143
• Main Authors: Guirro, Maria, Costa, Andrea, Gual-Grau, Andreu, Herrero, Pol, Torrell, Helena, Canela, Núria, Arola, Lluis
• Format: Journal Article
• Language: English
• Published: United States Public Library of Science 23.09.2019; Public Library of Science (PLoS)
• Subjects: Animals; Anti-Bacterial Agents - pharmacology; Antibiotics; Biochemistry; Biodiversity; Biology and Life Sciences; Biotechnology; Body Weight; Carbohydrates; Care and treatment; Comorbidity; Dehydrogenases; Depletion; Diet; Disease Models, Animal; Disruption; Dysbacteriosis; Dysbiosis; Ecosystems; Environmental changes; Epidemics; Etiology; Etiology (Medicine); Fecal Microbiota Transplantation; Fecal microflora; Feces; Gastrointestinal Microbiome - drug effects; Gut microbiota; High fat diet; Homeostasis; Infrastructure; Intestinal microflora; Male; Medicine and Health Sciences; Metabolism; Metabolites; Metagenome; Metagenomics; Metronidazole; Microbiota; Microbiota (Symbiotic organisms); Neomycin; Obesity; Obesity - physiopathology; Obesity - therapy; Rats; Risk factors; Studies; Surgery; Transplantation; England; United Kingdom > UK; United States > US; Spain
• DOI: 10.1371/journal.pone.0218143
• ISSN: 1932-6203

Obesity and its comorbidities are currently considered an epidemic, and the involved pathophysiology is well studied. Hypercaloric diets are tightly related to the obesity etiology and also cause alterations in gut microbiota functionality. Diet and antibiotics are known to play crucial roles in changes in the microbiota ecosystem and the disruption of its balance; therefore, the manipulation of gut microbiota may represent an accurate strategy to understand its relationship with obesity caused by diet. Fecal microbiota transplantation, during which fecal microbiota from a healthy donor is transplanted to an obese subject, has aroused interest as an effective approach for the treatment of obesity. To determine its success, a multiomics approach was used that combined metagenomics and metaproteomics to study microbiota composition and function. To do this, a study was performed in rats that evaluated the effect of a hypercaloric diet on the gut microbiota, and this was combined with antibiotic treatment to deplete the microbiota before fecal microbiota transplantation to verify its effects on gut microbiota-host homeostasis. Our results showed that a high-fat diet induces changes in microbiota biodiversity and alters its function in the host. Moreover, we found that antibiotics depleted the microbiota enough to reduce its bacterial content. Finally, we assessed the use of fecal microbiota transplantation as a complementary obesity therapy, and we found that it reversed the effects of antibiotics and reestablished the microbiota balance, which restored normal functioning and alleviated microbiota disruption. This new approach could be implemented to support the dietary and healthy habits recommended as a first option to maintain the homeostasis of the microbiota.